IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Nov 12, 2024 · 10-Q · 43 days after period end · 0000950170-24-125537
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$7.09M | -$7.17M | -$7.40M | -$3.39M |
| EPS Diluted | -$4.49 | -$0.23 | -$0.34 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end
